Kopran share news, announcements and annual reports
NSE: KOPRANBSE: 524280Pharmaceuticals & BiotechnologySmall Cap
Kopran Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, Jun 1999 on NSE
Last close ₹239.05down ₹12.95 (5.14%)BSE ₹239.30
Share price at the NSE close on 30 Oct 2026. Previous close ₹252.00.
30 Oct: open ₹253.80, high ₹253.80, low ₹237.50
52-week range of traded prices to 30 Oct 2026
₹107.00Low, 30 Mar 2026₹295.83High, 30 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,155 Cr1,663rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 46.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.26%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.29
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,52,24248.4% delivered
Kopran share news and announcements
451 announcements, routine notices left out, newest first. Page 9 of 10.
Jul 2009
29 Jul · Management
Kopran Ltd. has informed the Exchange vide notes to Accounts in the Un- audited Financial Results for the quarter ended June 30, 2009 (taken on record by the Board of Directors of the Company at its meeting held on July 29, 2009) regarding Auditors Observation :"(a)Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6952.26 Lacs, are in the opinion of the Auditors doubtful of realisation. In the opinion of the Management since the investment in the Subsidiary Company, Kopran Research Laboratories Ltd is long term for strategic reason , no provision is required to be made. b) Balances of some of the Debtors, Creditors, Loans & Advances are subject to confirmation, reconciliation and consequent adjustment, if any. However, in the opinion of the management such adjustments, if any, will not be material".22 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”2 Jul · Audit Qualifications/Management Comments
Kopran Ltd. has informed the Exchange vide notes to Accounts in the Audited Financial Results for the year ended March 31, 2009 (taken on record by the Board of Directors of the Company at its meeting held on June 30, 2009) regarding Auditor's observation: "(a) Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6935.92 Lacs are in the opinion of the Auditors doubtful of realisation. In the opinion of the Management since the investment in the Subsidiary Company, Kopran Research Laboratories Ltd is long term for strategic reasons, no provision is required to be made. (b) Balances of some of the Debtors, Creditors, Loans & Advances are subject to confirmation, reconciliation and consequent adjustment, if any. However, in the opinion of the management such adjustments, if any, will not be material".2 Jul · Board meeting
Kopran Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on June 30, 2009 has decided to issue on Preferential basis 19,50,000 Warrants and 18,50,000 equity shares of Rs.10/- each to the Promoters / Associates at a price arrived at as per SEBI Guidelines.
Jun 2009
15 Jun · Board meeting
To consider and approve Audited Financial Results for the Year Ended March 31, 2009.4 Jun · Updates
Kopran Ltd. has informed the Exchange vides its letter dated June 04, 2009 that: "Today morning there was minor fire in our Bulk Drug Plant at Mahad. We do not expect any material impact".
Apr 2009
9 Apr · Results
Kopran Ltd. has informed the Exchange that the Company will publish the Audited Financial Results within the period of 3 months from the end of the last Quarter of 2008-09 ending on March 31, 2009. Hence Company will not separately publish the Unaudited Financial Results for the last Quarter ending on March 31, 2009.
Mar 2009
2 Mar · Limited Review Report
Kopran Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December 31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
16 Feb · Disclosure
Kopran Ltd. has submitted to the Exchange disclosure under Regulation 8A(4) of SEBI (SAST) Regulation, 1997. The copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2009
31 Jan · Utilisation of Funds
Kopran Ltd. has informed the Exchange vide notes to Accounts in the Un-Audited Financial Results for quarter ended December 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on January 30, 2009) regarding auditors observation as follows: a) Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6427.60 Lacs in the opinion of the Auditors are doubtful of realization. In the opinion of the Management since the investment in the Subsidiary Company, Kopran Research Laboratories Ltd is long term for strategic reasons, no provision is required to be made. b) Balances of the Debtors, Creditors, loans & Advance are subject to confirmation, reconciliation and consequent and adjustment, if any. However, in the opinion of the management such adjustment. if any will not be material".21 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Dec 2008
19 Dec · Limited Review Report
Kopran Ltd. has informed the Exchange that the auditor's have conducted the limited review of the un-audited financial results for the quarter ended September 30, 2008 and found the same to be in order subject to certain observations. The auditor's observations are: "The Company has not prepared the Bank reconciliation Statements for the quarter ended September 30, 2008. As a result, we are unable to ensure accounting of all expenses."
Oct 2008
27 Oct · Management
Kopran Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended September 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on October 25, 2008) regarding Auditor's observation: "(a) Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6413.07 Lacs are in the opinion of the Auditors doubtful of realisation. In the opinion of the Management since the investment in the Subsidiary Company, Kopran Research Laboratories Ltd is long term for strategic reasons and is proposed to be merged with the Company, no provision is required to be made. (b) Balances of some of the Debtors, Creditors, Loans & Advances are subject to confirmation, reconciliation and consequent adjustment, if any. However, in the opinion of the management such adjustments, if any, will not be material".18 Oct · Board meeting
Meeting on 25 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”13 Oct · Updates
Kopran Ltd. has informed the Exchange that the Board of Directors, at its meeting held on October 11, 2008 has decided to divest its stake in the Joint Ventures namely, Globalpharma LLC, Dubai and Kampala Pharmaceutical Industries, Uganda.
Sep 2008
17 Sep · Limited Review Report
Kopran Ltd. has informed the Exchange that the auditor's have conducted the limited review of the Unaudited financial results for the quarter ended June 30, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.15 Sep · Meeting
Kopran Ltd. has informed the Exchange that the Annual General Meeting of the Company is scheduled to be held on September 27, 2008.5 Sep · Corporate action
Kopran Ltd. has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from September 24, 2008 to September 27, 2008 (both days inclusive) for the purpose of Annual General Meeting (AGM).
Aug 2008
7 Aug · Management
Kopran Ltd. has informed the Exchange vide notes to Accounts in the Unaudited Financial Results for the quarter ended June 30, 2008 (taken on record by the Board of Directors of the Company at its meeting held on July 30, 2008) regarding Auditor's observation: "(a) Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6418.51 Lacs in the opinion of the Auditors are doubtful of realisation. In the opinion of the Management since the Subsidiary Company, Kopran Research Laboratories Ltd is long term for strategic reasons and is proposed to be merged with the Company hence no provision is required to be made. (b) Balances of some of the Debtors, Creditors, Loans & Advances are subject to confirmation, reconciliation and consequent adjustment, if any. However, in the opinion of the management such adjustments, if any, will not be material".
Jul 2008
23 Jul · Board meeting
Meeting on 30 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”2 Jul · Management
Kopran Ltd. has informed the Exchange vide notes to Accounts in the Audited Financial Results for the period ended March 31, 2008 (taken on record by the Board of Directors of the Company at its meeting held on June 30, 2008) that: "Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6417.70 Lacs in the opinion of the Auditors are doubtful of realisation. In the opinion of the Management since the Subsidiary Company, Kopran Research Laboratories Ltd is long term for strategic reason and is proposed to be merged with the Company hence no provision is required to be made".
Jun 2008
24 Jun · Board meeting
To consider and approve Audited Financial Results for the Financial Year (Six months) Ended on March 31, 2008.
Mar 2008
25 Mar · Results
Kopran Ltd. has informed the Exchange that: "Company will publish the Audited Financial Results within the period of 3 months from the end of the last Quarter of 2007-08 ending on March 31, 2008. Hence Company will not separately publish the Unaudited Financial Results for the last Quarter ending on March 31, 2008".11 Mar · Limited Review Report
Kopran Ltd. has informed the Exchange that the auditor's have conducted the limited review of the unaudited financial results for the quarter ended December 31, 2007. The details of the limited review report shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2008
29 Feb · Corporate action
Kopran Ltd. has informed the Exchange that the Register of Members and Share Transfer Books of the Company will remain closed from March 24,2008 to March 26,2008 (both days inclusive) for the purpose of Annual General Meeting (AGM).12 Feb · Meeting
Kopran Ltd. has informed the Exchange that in accordance with the provisions of Section 81(1A) and Section 192A of the Companies Act 1956 read with the Companies (Passing of the Resolution by Postal Ballot) Rules, 2001. To consider and if thought fit, to give assent/dissent to the following Special Resolutions: (1) Issue of Equity Shares on preferential basis to IDBI. (2) Issue of Equity Shares on preferential basis to LIC. The Company has appointed Mr. Narayan Parekh, Practising Company Secretary as Scrutinizer for the purpose of Postal Ballot. Duly completed postal ballot should reach the company not later than the close of working hours on February 26, 2008. The result of Postal Ballot shall be announced by the Chairman or in his absence by any other person so authorized by the Chairman, on February 27, 2008. A copy of the postal ballot notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2008
28 Jan · Board meeting
Meeting of the Board of Directors scheduled to be held on January 28, 2008 to consider among various issue including approval of Unaudited Financial Results for the Quarter ended December 31, 2007 (Provisional) has been rescheduled due to non availability of directors and the same will be held on January 31, 2008. There is no change in the agenda items.22 Jan · Board meeting
Wherein the Board will consider and take on record the Unaudited Results for the Quarter Ended on December 31, 2007.11 Jan · Management
Kopran Ltd. has informed the Exchange regarding auditors observation vide notes to Accounts in the audited Financial Results for the period ended September 30, 2007 that : "Investments and Advances made to Subsidiary Company, Kopran Research Laboratories Ltd amounting to Rs. 6504.77 Lacs and Joint Venture, Golbalpharma Co. LLC amounting to Rs. 1196.56 Lacs which in the opinion of the Auditors are doubtful. In the opinion of the Management since the Subsidiary Company, Kopran Research Laboratories Ltd is Proposed to be merged and investments in Joint Venture, Global Pharma Co. LLC are made for long term period hence no provision is required to be made".10 Jan · Business
Kopran Ltd. has informed the Exchange that the Board of Directors of the Company at its extended meeting held on January 09, 2008, approved the proposal to issue and allot on preferential basis 581,656 equity shares to IDBI Bank and 200,000 equity shares to LIC as a part of the settlement of their dues.3 Jan · Board meeting
Consideration and approval of the audited financial results for the 18 months ended September 30, 2007 at the Board meeting, held on January 03, 2008, was adjourned. The matter would be considered at a Board meeting to be held on January 08, 2008.3 Jan · Board meeting
Kopran Ltd. has informed the Exchange that: The Board of Directors at its meeting held on January 3, 2008 has approved the assignment of its brand SMYLE to Maneesh Pharmaceuticals Ltd. for the consideration of Rs.52.88 crores. A range of more than twenty (20) products covering Oral Care, Pain Management and Baby products are being marketed successfully under the SMYLE brand. Maneesh Pharmaceuticals Ltd. has been distributing and marketing SMYLE range of products since the last two years, Kopran has been receiving Royalty on the sales of SMYLE products. The decision of the Board is a part of the objective to focus on the International business for pharmaceuticals products, both Formulations and Bulk Drugs. The consideration and approval of the audited financial results for the 18 months ended September 30, 2007 at the Board meeting, held on January 03, 2008, was adjourned. The matter would be considered at a Board meeting to be held on January 08, 2008.
Dec 2007
24 Dec · Board meeting
To consider and approve the Audited Financial Results for the extended Financial Year comprising of 18 months period, ended September 30, 2007.20 Dec · Meeting
Kopran Ltd. has informed the Exchange that: "The Shareholders have approved the issue and allotment of 59,09,000 warrants to Promoters/ Associates on preferential basis". Further the Company has submitted to the Exchange a copy of the minutes of the Extra Ordinary General Meeting of the Company held on December 19, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Nov 2007
29 Nov · Meeting
Kopran Ltd. has submitted to the Exchange a copy of the notice calling Extra Ordinary General Meeting to be held on December 19, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.19 Nov · Allotment of Warrants
Kopran Ltd. has informed the Exchange that: "The Board of Directors of the Company at their meeting held on November 19, 2007 has decided to issue and allot by way of preferential allotment of 59,09,000 warrants to Promoters / Associates".
Oct 2007
27 Oct · Results
Kopran Ltd. has informed the Exchange that the Company will publish the Audited Results for the 18 months period within 3 months of end of extended Financial Year i.e. before December 31, 2007.
Sep 2007
25 Sep · Board meeting
Kopran Ltd. has informed the Exchange regarding the Outcome of the Board Meeting held on September 21, 2007 as under: The Board of Directors of the Company have accepted the resignations of the following: (1) Mr. H.P.Vyas - Director (2) Mr. Rajesh Kumar Mundra - Company Secretary. Mr. Surendra Somani, Executive Vice Chairman is designated Compliance Officer of the Company at present. The Company further informed that the Company has received approval from the Registrar of Companies Maharashtra, Mumbai for extension of its Financial year from March 31, 2007 to September 30, 2007 vide their dated September 11, 2007. Accordingly the present Financial Year will be for a period of 18 months ending on September 30, 2007.17 Sep · Board meeting
Inter alia to consider and take on record the Audited Financial Results for the Quarter Ended on June 30, 2007.
Jul 2007
24 Jul · Results
Kopran Ltd. has informed the Exchange that Company will publish the Audited Results within the period of 3 months from the end of the last Quarter ended for the Financial Year i.e. June 30, 2007. Hence Company will publish the Audited Results on or before September 30, 2007.2 Jul · Management
Kopran Ltd. has informed the Exchange that : "(1) Investments and Advances made to Subsidiary Company, Kopran Research Laboratory Ltd amounting to Rs. 6555.57 Lacs and Joint Venture, Golbalpharma Co. LLC amounting to Rs. 1193.84 Lacs which in the opinion of the Auditors are doubtful. In the opinion of the Management since the Subsidiary Company, Kopran Research Laboratory Ltd is proposed to be merged and investments in Joint Venture, Golbalpharma Co. LLC are made for long term period hence no provision is required to be made. (2) Recognition of Export benefit under Target Plus Incentive Scheme proposed by the Govt. of Rs. 320 Lacs in earlier years, where later on export benefit under this scheme has been reduced retrospectively as per notification issued by the Govt. for which no provision has been made. In the opinion of the Management since this matter is pending before the Court hence no provision has been made".2 Jul · Board meeting
Kopran Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on June 30, 2007 has approved the allotment of 1244168 Equity Shares to UTI Bank Limited on account of conversion of loan into Equity Shares. The Board of Directors of the Company has accepted the resignations of the following Directors: 1) Mr. Bruno Beuque,2) Mr. Robert D. Petty.
Jun 2007
25 Jun · Board meeting
Wherein among the other matters, interalia to consider and take on record the Audited Results for upto the Quarter ended on March 31, 2007.20 Jun · Meeting
Kopran Ltd. has informed the Exchange regarding the Outcome of the Extra Ordinary General Meeting held on June 19, 2007 which is as follows: "We are pleased to inform you that the Shareholders have approved the allotment of 12,44,168 Equity Shares to UTI Bank Limited on Preferential Basis".20 Jun · Extension of Financial Year
Kopran Ltd. has informed the Exchange regarding the Outcome of the Board Meeting held on June 19, 2007 which is as follows: "We are pleased to inform you that the Board of Directors of the Company have approved the Extension of Financial Year by 3 months i.e. upto June 30, 2007 (15 months)".
May 2007
29 May · Meeting
Kopran Ltd. has submitted to the Exchange copy of the Notice calling Extra-Ordinary General Meeting of the Members of Kopran Limited which will be held on June 19, 2007. For more details click here.3 May · Results
Kopran Ltd. has informed the Exchange that the Company shall publish Audited Financial Results within a period of 3 month for the year ended on March 31, 2007 i.e. on or before June 30, 2007.3 May · Issue of shares/Others
Kopran Ltd. has informed the Exchange that outcome of Board meeting held on April 30, 2007 is as under :- (1) Change in Management : (a) Board of Directors have approved the appointment of Mr. V.N. Khanna and Dr. A.K.Mehta as an Additional Directors of the Company. (b) Board of Directors have approved the appointment of Mr. Rajesh Kumar Mundra as a Company Secretary & Compliance Officer of the Company. (c) Board of Directors have accepted the resignation of the following Directors :- (1) Mr. C.L. Jain - with effect from 8th February, 2007. (2) Dr. A.C. Shah - with effect from 4th April, 2007. (2) Issue and Allotment of Equity Shares - Board has approved issue and allotment of 12,00,162 Equity Shares to necessary approval to UTI Bank Limited."
Apr 2007
23 Apr · Board meeting
Among the other matters, inter alia to consider and take on record the Unaudited Results for the quarter ended on March 31, 2007
Feb 2007
5 Feb · Management
Kopran Ltd. has informed the Exchange that "The resignation of Mr. Sumeet S. Maheshwari, Company Secretary of the Company has been accepted by the Board of Directors of the Company in their meeting held on 31st January, 2007. Mr. Surendra Somani, Executive Vice Chairman is the Compliance Officer of the Company at present."